Iroquois Capital Management, LLC 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:12 pm Sale | 2024-09-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Iroquois Capital Management, LLC | 2,242 0.670% | -894,379 (-99.75%) | Filing |
| 2024-08-08 4:24 pm Unchanged | 2024-07-19 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Iroquois Capital Management, LLC | 896,621 9.990% | 0 (Unchanged) | Filing |
| 2024-08-05 09:00 am Purchase | 2024-07-19 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Iroquois Capital Management, LLC | 896,621 9.990% | 896,621 (New Position) | Filing |